Physical and mechanical properties of polymer modified self-compacting concrete (SCC) using natural and recycled aggregates

The study researched the effectiveness of four polymer admixtures (3%, 5%, 10%, and 15% of water weight) on the fresh and hardened properties of self-compacting concrete (SCC) cast using recycled and natural aggregates. Results show that polymer additives had positive effects on the fresh properties of SCC using recycled aggregates. Incorporating polymer additives increased the filling ability of concrete by more than four times. All polymer modified SCCs had a 100% passing ability compared to the 80% passing ability of the control samples. The compressive strength of materials at similar polymer ratios decreased by about 50% when natural aggregates were replaced with recycled aggregates. The flexural strength of SCC including recycled aggregates with 15% polymer was maintained compared to the control SCC including natural aggregates. The addition of 15% polymer to recycled aggregates concrete could improve workability and maintain flexural strength

Atorvastatin and flaxseed effects on biochemical indices and hepatic fat of NAFLD model in rats

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver disease that affects about 25% of the general population. No definitive treatment for NAFLD has been identified yet. The aim was to determine the effect of atorvastatin (ATO) and flaxseed on related indicators of NAFLD-induced fat/fructose-enriched diet (FFD). Materials and Methods: Forty male Wistar rats were divided into five groups. NAFLD groups received FFD and carbon tetrachloride (CCl4) to induce NAFLD. After intervention with ATO (10 mg/kg/day) and/or flaxseed (7.5 g/kg/day), liver enzymes and lipid profiles in serum were determined at eight week of interventions. Results: Triglycerides (TG) and cholesterol (CHO) in FFD + ATO, FFD + flaxseed, and FFD + ATO + flaxseed had a significant decrease and low-density lipoprotein (LDL) level and LDL/high-density lipoprotein (HDL) ratio showed a significant increase in the FFD + flaxseed compared to the FFD. The levels of aspartate transaminase (AST), alanine transaminase (ALT), and gamma-glutamyltransferase (GGT) were significantly reduced in the FFD + ATO, FFD + flaxseed, and the FFD + ATO + flaxseed. In addition, Alkaline phosphatase (ALP) levels were significantly different between normal and FFD. Fasting blood sugar (FBS) levels were significantly different in the FFD + flaxseed and the FFD + ATO + flaxseed compared to the FFD. Conclusion: ATO therapy along with flaxseed controls NAFLD-related indices and FBS. Therefore, it can be stated with caution that ATO and flaxseed can be used to improve lipid profile and reduce the complications of NAFLD